South Korea Cell Expansion Market Insight
Published: 27 June 2026 | Report Format: Electronic (PDF) | Author: Govind and Krishna
The increased demand for cell treatment, investments in biopharmaceutical R&D, sophisticated infrastructure for regenerative medicine, South Korean cell expansion market is growing at compound annual growth rate (CAGR) of 14.18%.
South Korea Cell Expansion Market Insights Forecasts to 2035
- The South Korea Cell Expansion Market Size Was Estimated USD 318.8 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 14.18% from 2025 to 2035
- The South Korea Cell Expansion Market Size is Expected to rise around USD 1200.3 Million by 2035
Notable Insights for the South Korea Cell Expansion Market
- Consumables like culture medium and reagents predominate based on product segmentation, whereas automated expansion systems and bioreactors are rapidly adopted for large-scale manufacturing.
- Driven by growing pipeline and clinical trial activity, biopharmaceutical companies and CMOs are at the top of the end-user segmentation, followed by research institutes and cell banks.
- The revised Advanced Regenerative Bio Act in South Korea facilitates the commercialization of cell treatment, the development of infrastructure, and reimbursement channels. Meanwhile, growing biopharmaceutical investments propel the growth of the cell expansion market across the country.
- Through biopharmaceutical investments, research, and commercialization efforts, South Korea's cell and gene therapy industry is growing quickly, with businesses concentrating on lowering therapy costs and enhancing accessibility.
Download the eBook (ToC)
Research Methodologies Used to Analyze the South Korea Cell Expansion Market
Market research for the South Korea cell expansion market is done through a mix of both primary and secondary research methodologies so that an accurate evaluation of market dynamics can be made. In the case of primary research, interviews are held with biotechnology firms, cell therapy companies, research centers, hospitals, CDMOs, and experts in the industry in order to gauge the demand trends, technology trends, and competitive trends. In terms of secondary research, reports by companies, government documents, journals, scientific writings, trade databases, and other official documents pertaining to biotechnology and regenerative medicine are analyzed.
Decisions Advisors Research Methodology: Trusted Insights for Strategic Decision-Making
What is Decisions Advisors Research?
Decisions Advisors research delivers comprehensive market intelligence through detailed industry analysis, competitive benchmarking, trend forecasting, and data-driven business insights. Our research methodology combines advanced analytical frameworks with extensive primary and secondary research to help organizations make informed and strategic business decisions.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the South Korea Cell Expansion Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in South Korea Cell Expansion Market
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Sartorius AG
- Miltenyi Biotec
- Eppendorf AG
- PL BioScience GmbH
- Lonza Group
- Corning Inc.
- STEMCELL Technologies Inc.
- GE Healthcare
Recent Developments:
- In March 2025, Thermo Fisher Scientific Inc. strengthened the adoption of scalable cell expansion workflows in biopharma production networks by expanding cell culture and cell therapy manufacturing solutions through Asia-Pacific partnerships.
- In October 2024, Merck KGaA introduced upgraded Mobius cell expansion bioprocess platforms that facilitate the production of advanced cell therapy and allow for greater scalability for applications in regenerative medicine throughout Asian markets.
Market Segmentation:
South Korea Cell Expansion Market, By Product Type
- Consumables (Media, Reagents, Sera)
- Instruments (Bioreactors, Cell Counters, Automated Systems)
- Culture Flasks & Accessories
South Korea Cell Expansion Market, By Technology
- Biopharmaceutical & Biotechnology Companies
- Contract Manufacturing Organizations (CMOs)
- Research Institutes & Cell Banks
South Korea Cell Expansion Market, By Application
- Cell Therapy Development
- Regenerative Medicine Research
- Biopharmaceutical Production
Expert Views:
The South Korea cell expansion market is growing at a rapid rate due to the high demand for cell therapy, technological advances in regenerative medicine, and higher biopharmaceutical research and development investments. The expansion of bioprocessing technologies and consumables ensures scalability of manufacturing processes. In addition, good regulatory environment coupled with active participation of contract manufacturing organizations and biotechnology companies helps to boost market growth.
Author: Govind and Krishna By Decisions Advisors and Consulting